glutathione intravenous dosage Injections: Benefits, Dosage, and Costs How Much is Too Much?

A multicentre, double-blind randomized clinical trial

A categorical shift from near-zero to clinically meaningful

However, animal safety does not invariably ensure human safety

Continued TABLE 7

Research suggests GHK-Cu does not appear to develop tolerance like many pharmaceuticals, but cycling remains prudent practice

Clinical translation requires human CSF pharmacokinetic assays to prove BBB bypass, a rigorous dose-escalation Phase I trial to establish a safe human NOAEL for chronic dosing, and an RCT utilizing precise neurocognitive testing (e.g., MoCA) to confirm that murine transcriptomic shifts yield functional neuroprotection in humans